Bionic Vision Australia (BVA), a consortium of some of Australia’s leading universities and research institutes, and funded by the Australian Research Council from 2010, ceased operations on 31 December 2016. The technologies developed by the consortium are now being commercialised by Bionic Vision Technologies Pty Ltd (BVT).

About BVA

BVA was a national consortium of researchers (2010 - 2016) working together to develop bionic eye devices. The aim of this technology is to restore the sense of vision to people with vision impairment due to retinitis pigmentosa and age-related macular degeneration.
The BVA bionic eye project brings together a cross-disciplinary group of world-leading experts in the fields of : Ophthalmology, biomedical engineering, electrical engineering and materials science, neuroscience, vision science, psychophysics, wireless integrated-circuit design, surgical, preclinical and clinical practice. In December 2009, the Australian Federal Government awarded a $42 million ARC grant to Bionic Vision Australia to develop bionic vision technology.

“ It is exciting to be doing research that has such potential to provide enormous benefit to people not only with retinal degenerative diseases, but now a whole range of neurological conditions. It is immensely rewarding to reflect on the enormous technical achievements made in just five years of funded research, and to look ahead to what might be achieved in the future. ”

- Professor Anthony N. Burkitt Director, Bionic Vision Australia
For more information on the Bionic Eye, BVA researchers or opportunities for students, please visit:

BVA Members

BVA Partners

An Initiative of